Dr. Vivek Subbiah, drug development chief at the Sarah Cannon Research Institute, discusses medical advances to treat cancer ...

The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...

Daiichi Sankyo and Merck said on Tuesday that their drug, patritumab deruxtecan, met the main goal of extending the time some ...

Novartis said its Kisqali breast cancer drug produced longer success for those with certain forms of the disease.

Novartis AG’s breast cancer drug helped prevent the disease coming back a year after treatment had ended, in new data that ...

Although immunotherapy and chemotherapy are both used to treat cancer, there are differences in their modes of action and ...

Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent ...

Drug treatments for blood cancers have evolved. In the past, myeloma patients received two drugs in sequence—two after two.

Promising Triple Negative Breast Cancer Pipeline Therapies in the various stages of development include Nanosomal Docetaxel ...

Two complementary studies from the Faculty of Medical and Health Sciences at Tel Aviv University, in collaboration with the ...

Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease.

Women with early stage breast cancer may now take Kisquali, a medication already approved for advanced disease, fo ...